GEN Exclusives

More »

GEN News Highlights

More »
Mar 12, 2007

Protherics Receives over $19M Milestone from AstraZeneca

  • Protherics reports that a £10-million milestone payment from AstraZeneca was triggered as a result of the successful scale-up of the CytoFab™ manufacturing process to a 600-L batch size.

    Upon receipt of this manufacturing-related milestone of over $19M, Protherics will have received a total of GBP26.3 million, or over $50.7 million, in milestone payments from AstraZeneca since the deal was signed in December 2005.

    Under the licensing agreement, Protherics may receive up to a further £161 million, or about $310 million, in milestone payments, in addition to a 20% royalty on global net product sales of CytoFab™.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?